By analyzing MYBBP1A mRNA levels in paired samples of normal and tumoral tissue, MYBBP1A expression levels have been found to be reduced mainly in the kidney, liver and pancreas tumors [38]. The gene discussed is MYBBP1A; the disease is pancreatic neoplasm.